021-51111890
购物车（0）
sales@molnova.cn
Cevidoplenib dimesylate hydrochloride
CAS No. 269062-93-3
Cevidoplenib dimesylate hydrochloride ( Cevidoplenib dimesylate hydrochloride(2043659-93-2 Free base) )
产品货号. M28906 CAS No. 269062-93-3
Cevidoplenib dimesylate HydroHClide 是一种脾酪氨酸激酶 (Syk) 抑制剂，具有潜在的免疫调节和抗炎特性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2009 | 有现货 |
|
| 10MG | ￥3216 | 有现货 |
|
| 25MG | ￥5370 | 有现货 |
|
| 50MG | ￥7655 | 有现货 |
|
| 100MG | ￥10368 | 有现货 |
|
| 500MG | ￥20817 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Cevidoplenib dimesylate hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Cevidoplenib dimesylate HydroHClide 是一种脾酪氨酸激酶 (Syk) 抑制剂，具有潜在的免疫调节和抗炎特性。
-
产品描述Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.(In Vitro):Cevidoplenib dimesylate hydrochloride(oral) inhibited the activity of SYK and blocked Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, mast cells, natural killer cells, B cells, and neutrophils.
-
体外实验——
-
体内实验——
-
同义词Cevidoplenib dimesylate hydrochloride(2043659-93-2 Free base)
-
通路Angiogenesis
-
靶点Syk
-
受体Adenylyl cyclase (AC)
-
研究领域——
-
适应症——
化学信息
-
CAS Number269062-93-3
-
分子量1957.9
-
分子式C90H132Cl5N27O12
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESNCCCC[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H]3N(C([C@H](CC4=CNC5=C4C=CC=C5)NC([C@H](CC6=CNC7=C6C=CC=C7)NC([C@H]8N(C([C@H](CC9=CNC%10=C9C=CC=C%10)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H]([C@@H](C)CC)N)=
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ramos-Espiritu L, et al. Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase. Nat Chem Biol. 2016 Oct;12(10):838-44.
